Accuray Inc - Company Profile
Powered by 
All the data and insights you need on Accuray Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Accuray Inc Strategy Report
- Understand Accuray Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Accuray Inc (Accuray) is a medical device company that focuses on the development, manufacture and sale of personalized treatment solutions for radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company’s major products include CyberKnife robotic radiosurgery systems, TomoTherapy system, Radixact delivery treatment platform and Software Solutions. Its flagship product, CyberKnife robotic radiosurgery system is designed to treat tumors anywhere in the body non-invasively with an accuracy of sub-millimeter. TomoTherapy system combines a CT scanner with a radiation treatment delivery system that is used by healthcare professionals in the treatment of a wide range of cancer types. Its major services include post-contract customer support, training, installation services and other professional services. The company sells its products in the US and through distributors in Latin America, Europe, and Asia. Accuray is headquartered in Sunnyvale, California, the US.
Headquarters
United States of America
Address
1240 Deming Way, Madison, Wisconsin, 53717
Website
www.accuray.com
Telephone
1 608 8242800
No of Employees
1,024
Industry
Medical Equipment
Ticker Symbol & Exchange
ARAY (NASD)
Revenue (2022)
$447.6M
4.1%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-73.6%
(2022 vs 2021)
Market Cap*
$217.2M
Net Profit Margin (2022)
XYZ
-66.9%
(2022 vs 2021)
* As of and is in US$
Accuray Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| - | - | - |
| CyberKnife Systems | Site Planning and Installation | Accuray Logo |
| Onrad Delivery System | Training | Accuray |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Corporate Changes/Expansions | In April, the company opened a new training center in Genolier, Switzerland. |
| 2023 | Regulatory Approval | In August, the company received approval from US Food and Drug Administration (FDA) for its VitalHold breast package on the Radixact system. |
| 2022 | Contracts/Agreements | In October, the company and GE HealthCare entered into a partnership to advance the practice of radiation therapy and deliver personalized care to patients diagnosed with cancer. |
Competitor Comparison
| Key Parameters | Accuray Inc | Varian Medical Systems Inc | Elekta AB | ViewRay Inc | BrainLAB AG |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Sweden | United States of America | Germany |
| City | Madison | Palo Alto | Stockholm | Oakwood Village | Munich |
| State/Province | Wisconsin | California | - | Ohio | Bayern |
| No. of Employees | 1,024 | - | 4,584 | 295 | 2,200 |
| Entity Type | Public | Private | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| James M. Hindman | Chairman | Executive Board | 2010 | 61 |
| Suzanne Winter | Chief Executive Officer; President; Director | Executive Board | 2022 | 59 |
| Ali Pervaiz | Chief Financial Officer; Senior Vice President | Senior Management | 2022 | - |
| Franco N. Palomba | Vice President; Chief Accounting Officer; Controller | Senior Management | 2022 | - |
| Patrick Spine | Senior Vice President; Chief Administrative Officer | Senior Management | 2018 | 51 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer